YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
* Akari Therapeutics press release [https://seekingalpha.com/filing/309948312] (AKTX [https://seekingalpha.com/symbol/AKTX]): Q2 net loss was $4.8 million, compared with $1.9 million for the second quarter of 2025. * Cash totaled $7.7 mill…
Virtual Investor "What This Means" segment highlights strategic Whitehawk collaboration, accelerating industry validation of novel ADC payloads, and Akari's differentiated PH1 platform Watch the “What This Means” video here TAMPA, Fla. and…
(RTTNews) - Akari Therapeutics, Plc. (AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs announced a strategic research collaboration with Whitehawk Therapeutics, Inc. (WHWK), a clinical-stage oncology thera…
European equities traded in the US as American depositary receipts were tracking higher late Thursda PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
European equities traded in the US as American depositary receipts started the trading week lower la PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
(RTTNews) - In Thursday's list of gainers, we highlight SciSparc, which received the regulatory go-ahead to acquire a stake in a private Israeli technology company, Co-Diagnostics, which extended its rally for the third straight day, and T…
By Karen Roman Akari Therapeutics, Plc (Nasdaq: AKTX) said President and CEO Abizer Gaslightwala was part of a Virtual Investor “What This Means” interview highlighting the company’s first abstract acceptance at the 2026 American Society o…
European equities traded in the US as American depositary receipts were trending slightly lower late PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
(RTTNews) - Biotech stocks witnessed strong momentum on Friday, with Akari Therapeutics leading the pack, driven by encouraging preclinical pancreatic cancer data for AKTX-101. MetaVia, GeoVax, Polyrizon, and Sol-Gel were also some of the…
(RTTNews) - Shares of Akari Therapeutics, Plc (AKTX) are up over 100% in pre-market trading after the company reported breakthrough preclinical data demonstrating that its lead antibody-drug conjugate, AKTX-101, works synergistically with…
[Pharmacist preparing capsules in a laboratory] Wirestock/iStock via Getty Images Akari Therapeutics (AKTX [https://seekingalpha.com/symbol/AKTX]) on Thursday announced promising preclinical data demonstrating that its lead cancer therapy,…
(RTTNews) - Today's gainers include CODX, which rallied for the third straight day; Akari, on breakthrough clinical data in pancreatic cancer; Sunshine, following regulatory approval for its generic Amoxicillin; GOVX, amid Ebola concerns;…
European equities traded in the US as American depositary receipts were tracking marginally lower la PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
European equities traded in the US as American depositary receipts were moving higher late Thursday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium ne…
European equities traded in the US as American depositary receipts were little changed late Wednesda PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
European equities traded in the US as American depositary receipts were down significantly late Tues PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
European equities traded in the US as American depositary receipts opened the week on a flat note Mo PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
European equities traded in the US as American depositary receipts were tracking higher late Wednesd PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
European equities traded in the US as American depositary receipts kicked off the week lower late Mo PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
European equities traded in the US as American depositary receipts were trending marginally higher l PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
European equities traded in the US as American depositary receipts were trending lower late Monday m PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Patent covers proprietary 2nd generation Thailanstatin analog payload designed for use in ADCs (antibody-drug conjugates) targeting cancer Approval strengthens Akari’s global intellectual property across all major markets and supports adva…
European equities traded in the US as American depositary receipts eased late Thursday morning with PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium ne…
We recently compiled a list of the 8 Oversold Biotech Stocks to Invest In Now. Akari Therapeutics, plc is among the oversold stocks to invest in. TheFly reported on April 8 that Maxim Group downgraded AKTX from Buy to Hold and did not assi…
European equities traded in the US as American depositary receipts were tracking higher late Friday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium ne…
Maxim downgraded Akari Therapeutics (AKTX) to Hold from Buy without a price target The selloff post the partnership with WuXi XDC is due in part due to Akari’s additional capital needs and continued pressure following the ratio change that…
Akari Therapeutics Plc CEO Abizer Gaslightwala discusses the Company’s strategic partnership with WuXi XDC and its implications for platform validation and development acceleration Company highlights accelerated IND timeline for AKTX-101 a…
European equities traded in the US as American depositary receipts were trending sharply higher late PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
(RTTNews) - Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody-drug conjugates (ADCs) with novel RNA splicing modulating payloads, announced a strategic partnership with WuXi XDC to accelerate dev…
[Scientist in a clean room] * Akari Therapeutics (AKTX [https://seekingalpha.com/symbol/AKTX]) partnered with WuXi XDC, a subsidiary of WuXi Biologics (WXXWY [https://seekingalpha.com/symbol/WXXWY]), to accelerate the development of its ne…
Akari Therapeutics Plc Strategic Partnership Enables Akari to Accelerate IND Filing By Late 2026 TAMPA, Fla. and LONDON, April 06, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developin…
European equities traded in the US as American depositary receipts were lower late Thursday morning, PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
European equities traded in the US as American depositary receipts were lower late Tuesday morning, PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium ne…
European equities traded in the US as American depositary receipts were down sharply late Thursday m PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
European equities traded in the US as American depositary receipts fell late Wednesday morning with PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium ne…
* Akari Therapeutics (AKTX [https://seekingalpha.com/symbol/AKTX]) will change its ADS ratio [https://seekingalpha.com/pr/20441590-akari-therapeutics-announces-ads-ratio-change] from 1:2,000 to 1:80,000 effective March 31, 2026. * The move…